These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 17062140

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine.
    Prota A, Vogt J, Pilger B, Perozzo R, Wurth C, Marquez VE, Russ P, Schulz GE, Folkers G, Scapozza L.
    Biochemistry; 2000 Aug 08; 39(31):9597-603. PubMed ID: 10924157
    [Abstract] [Full Text] [Related]

  • 6. Structural studies of thymidine kinases from Bacillus anthracis and Bacillus cereus provide insights into quaternary structure and conformational changes upon substrate binding.
    Kosinska U, Carnrot C, Sandrini MP, Clausen AR, Wang L, Piskur J, Eriksson S, Eklund H.
    FEBS J; 2007 Feb 08; 274(3):727-37. PubMed ID: 17288553
    [Abstract] [Full Text] [Related]

  • 7. Identification of the ATP-binding domain of vaccinia virus thymidine kinase.
    Black ME, Hruby DE.
    J Biol Chem; 1990 Oct 15; 265(29):17584-92. PubMed ID: 2211649
    [Abstract] [Full Text] [Related]

  • 8. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
    El Omari K, Liekens S, Bird LE, Balzarini J, Stammers DK.
    Mol Pharmacol; 2006 Jun 15; 69(6):1891-6. PubMed ID: 16556772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase.
    Kussmann-Gerber S, Kuonen O, Folkers G, Pilger BD, Scapozza L.
    Eur J Biochem; 1998 Jul 15; 255(2):472-81. PubMed ID: 9716390
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Computer-aided active-site-directed modeling of the herpes simplex virus 1 and human thymidine kinase.
    Folkers G, Trumpp-Kallmeyer S, Gutbrod O, Krickl S, Fetzer J, Keil GM.
    J Comput Aided Mol Des; 1991 Oct 15; 5(5):385-404. PubMed ID: 1663155
    [Abstract] [Full Text] [Related]

  • 14. Effect on substrate binding of an alteration at the conserved aspartic acid-162 in herpes simplex virus type 1 thymidine kinase.
    Black ME, Rechtin TM, Drake RR.
    J Gen Virol; 1996 Jul 15; 77 ( Pt 7)():1521-7. PubMed ID: 8757995
    [Abstract] [Full Text] [Related]

  • 15. Tight binding of deoxyribonucleotide triphosphates to human thymidine kinase 2 expressed in Escherichia coli. Purification and partial characterization of its dimeric and tetrameric forms.
    Barroso JF, Elholm M, Flatmark T.
    Biochemistry; 2003 Dec 30; 42(51):15158-69. PubMed ID: 14690426
    [Abstract] [Full Text] [Related]

  • 16. Crystal structure of varicella zoster virus thymidine kinase.
    Bird LE, Ren J, Wright A, Leslie KD, Degrève B, Balzarini J, Stammers DK.
    J Biol Chem; 2003 Jul 04; 278(27):24680-7. PubMed ID: 12686543
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of vaccinia virus thymidine kinase by the distal products of its own metabolic pathway.
    Hruby DE.
    Virus Res; 1985 Mar 04; 2(2):151-6. PubMed ID: 3993232
    [Abstract] [Full Text] [Related]

  • 18. Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography.
    Vogt J, Perozzo R, Pautsch A, Prota A, Schelling P, Pilger B, Folkers G, Scapozza L, Schulz GE.
    Proteins; 2000 Dec 01; 41(4):545-53. PubMed ID: 11056041
    [Abstract] [Full Text] [Related]

  • 19. Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.
    Hussein IT, Miguel RN, Tiley LS, Field HJ.
    Arch Virol; 2008 Dec 01; 153(3):495-505. PubMed ID: 18196203
    [Abstract] [Full Text] [Related]

  • 20. Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.
    Prichard MN, Keith KA, Johnson MP, Harden EA, McBrayer A, Luo M, Qiu S, Chattopadhyay D, Fan X, Torrence PF, Kern ER.
    Antimicrob Agents Chemother; 2007 May 01; 51(5):1795-803. PubMed ID: 17325220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.